Pharmaceutical innovation: Possibilities and limits of personalised medicine 1, 2

Author：

ISSN： 1436-9990

Source： Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol.51, Iss.6, 2008-06, pp. : 675-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalised cancer medicine

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 2, 2015-07 ,pp. : 262-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalised medicine—the potential yet realised

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 125, Iss. 3, 2018-02 ,pp. : 351-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalised Medicine for Asthma and Chronic Obstructive Pulmonary Disease

Respiration, Vol. 93, Iss. 3, 2017-01 ,pp. : 153-161

Karger

Access to resources Recommend Favorite

Possibilities and limits of treatment in patients with thrombotic thrombocytopenic purpura

By Gašparović V. Radonić R. Mejić Stanka Pisl Z. Radman I.

Intensive Care Medicine, Vol. 26, Iss. 11, 2000-11 ,pp. : 1690-1693

Springer Publishing Company

Access to resources Recommend Favorite

Editorial Letter: Promoting Predictive, Preventive and Personalised Medicine in global scale

By Golubnitschaja Olga

The EPMA Journal, Vol. 1, Iss. 4, 2010-12 ,pp. : 523-524

Springer Publishing Company

Access to resources Recommend Favorite